George W. Sledge

机构：Stanford Medicine, Caris Life Sciences (United States), Stanford University · ORCID：0000-0003-0297-0775

发表论文 107 篇 · 总被引 4647 次 · h-index 17

代表论文

• 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) (2020 · Annals of Oncology · 被引 1401)
• 4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4) (2021 · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 被引 226)
• A Real-World Experience in Pan-Tumor Testing for HER2 IHC in More Than 65 000 Solid Tumors (2025 · JAMA Oncology · 被引 7)
• Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials (2026 · The Lancet · 被引 4)
• 215P Impact of HER2 low on survival in patients treated with standard therapies in advanced breast cancer (2023 · ESMO Open · 被引 3)
• Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapy (2026 · Cancer Immunology Immunotherapy · 被引 2)